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Introduction
Variations in successive heart rate (HR) and RR intervals [the 
peak of the Q, R, and S waves of the electrocardiogram (ECG)] 
simultaneously are described as heart rate variability (HRV), 
which is the conventionally accepted term to portray variations 
of RR intervals1. HRV is an autonomous nervous system (ANS) 
marker that may provide reliable information for both disease 
prevention and diagnosis2,3, while it is frequently applied to sport 
settings4,5. Furthermore, HRV can be used as a tool to identify 
physiological6,7 and psychological8,9 disorders, while it has been 
utilised for diagnosis in both clinical10 and non-clinical studies11.
Regarding sport settings, HRV is primarily utilized to determine 
training loads12–14 and endurance training adaptation15,16. The 
wide use of HRV in both clinical and basic research as a 
diagnostic criterion has resulted in increased production of 
HRV-related equipment and software. Reference gold standard 
such as Power Lab (AD Instruments, Australia) and Reynolds 
Pathfinder program (Reynolds Medical Limited, United Kingdom) 
were developed and used extensively when compared with 
other HR monitors (i.e. Polar)17. However, most of these innova-
tions present disadvantages, such as difficulty of access and high 
cost18. To address these issues, more practical and cost-effective 
HRV tools were developed. The Polar RS800CX HR monitor 
(Polar Electro, Finland) was presented19–21 as a valid HR monitor 
for HRV analysis during rest and stress conditions (e.g. exercise). 
To date, however, the wide spectrum of HRV indices (i.e. time 
and frequency domain, Poincaré and recurrence plot) has not 
been tested for validation in the Polar RS800CX. Also, the 
performance of Polar RS800CX in post-stress conditions has 
not been extensively investigated to date. Therefore, the purpose 
of this study was to assess the validity of Polar RS800CX in 
a large spectrum of HRV indices by comparing it with results 
gained using an ECG monitor during rest, exercise (cycling) and 
recovery.
Methods
Volunteers and experimental protocol
An informed written consent form was signed by and obtained 
from 32 apparently healthy males [age: 24.78±6.87, body mass 
index (BMI): 24.48±3.13 kg/m2] with no history of respira-
tory, metabolic, or cardiovascular conditions. Participants were 
recruited via flyers from the university population and the local 
community in Trikala, Thessaly, Greece between June and 
November 2012. Participants who responded to our flyer 
advertisement were then interviewed to determine eligibility and 
they were informed of all experimental procedures, associated 
risks, and discomforts, before providing written informed con-
sent. The sample size was a sample of convenience. We included 
only male participants to avoid discomfort for females due to 
potential menstrual cycle. Ethical approval was obtained from the 
Ethics Review Board of the University of Thessaly (Protocol no. 
469).
All participants visited the Environmental Physiology Laboratory 
in the Department of Exercise Science only once; they were 
instructed to refrain from food, caffeine and strenuous exercise 
12 hours prior to the visit. Participants arrived at the physiology 
laboratory between 7–8 am and they were subject to height 
(cm) and weight (kg) measurements via a Seca 220 (Hamburg, 
Germany) device. Subsequently, both a Polar RS800CX (Polar 
Electro Ov, Kempele, Finland) and a 12-lead ECG (Welch Allyn, 
CardioPerfect, New York, USA) monitors were adjusted to 
participants who then remained in a supine position on a com-
fortable bed and rested for 20 minutes in a quiet room at thermo- 
neutral conditions (22–24°C and 40–60% relative humidity). 
Immediately after the 20 minutes of resting, participants 
performed an aerobic exercise session on a cycle-ergometer 
(Monark, Ergomedic) at 60% of their maximum HR for 
20 minutes. The maximum HR was calculated using Karvonen’s 
formula22: [(220 – age) – resting HR] * 0.60 + resting HR]. At 
the end of the exercise period, the participants rested in a supine 
position for another 20 minutes for the post-exercise recovery 
period. To avoid any displacement, an investigator continuously 
checked the position of both the chest belt of the Polar RS800CX 
and the electrodes of the ECG, throughout the experiment. 
Data were collected throughout the experimental trial using 
both a Polar RS800CX and an ECG, as previously described23,24. 
For the Polar RS800CX the data downloaded and saved in a 
text format via Polar ProTrainer 5 software, while the ECG data 
were collected via the Welch Allyn, CardioPerfect Workstation 
1.6.6 software. 
Analysis of heart rate variability indices
The raw data of the RR intervals of both the Polar RS800CX and 
the ECG were analysed using Premium Kubios HRV Analysis 
Software v1.1 (Biomedical Signal Analysis Group, University of 
Kuopio, Finland 2002). The retrieved HRV indices covered the 
time domain, frequency domain, Poincaré plot and recurrence plot 
indices (Table 1–Table 3).
Statistical analyses
Normal distribution was checked via Shapiro-Wilk test. Due to 
non-normal distribution, a two-step transformation was used to 
normalise all HRV variables, given that the Bland–Altman 
method requires normally distributed data25. Pearson’s correla-
tion coefficient was employed to assess the associations and 
paired-sample t-tests to calculate the mean differences of HRV 
indices between the Polar RS800CX and the ECG during rest, 
exercise and recovery. The Bland–Altman plots and the 95% 
limits of agreement (95%LoA) were used to calculate agree-
ment for all HRV indices during rest, exercise and recovery. 
We also calculated effect sizes between the Polar RS800CX 
and the ECG via the Cohen’s D pooled effect size analysis for 
each HRV index during rest, exercise and recovery. We esti-
mated the error rate of Mean RR intervals during rest, cycling and 
recovery, with the following equation: [(Mean RR ECG – Mean 
RR RS800CX)/Mean RR ECG] × 100. Missing data were 
removed from the analysis, given that they were missing at 
random. The statistical analysis was completed using IBM 
SPSS v24 and the level of significance was set at p<0.05. 
Results
The results of the Pearson correlation coefficient, paired- 
sample t-tests, 95%LoA and Cohen’s D pooled effect size 
analyses appear in Table 1 for the resting period, Table 2 for the 
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Table 1. Heart rate variability indices during the resting period. Values for ECG and RS800CX 
presented as mean ± standard deviation.
Variable ECG‡ RS800CX‡ Correlation Bias LoA Effect size
Time domain
Mean RR (ms) 947.2±151.6 944.9±140.4 0.91* 2.2 -118.08–122.6 0.02
STDRR (ms) 85.2±24.2 81.2±28.04 0.92* 4.02 -18.06–26.1 0.15
Mean HR [1/min] 63.9±19.5 66.7±17.5 0.89* -2.7 -20.4–14.8 0.15
STDHR [1/min] 6.1±4.3 6.3±2.9 0.89* -0.3 -4.7–4.01 0.04
RMSSD (ms) 76.5±32.2 67.5±27.4 0.86* 7.1# -24.4–38.7 0.29 (small) 
NN50 [beats] 210.9±88.6 200.9±89.4 0.95* 4.9 -49.5–59.4 0.11
pNN50 (%) 35.1±14.4 33.6±15.3 0.92* 0.6 -11.07–12.4 0.10
HRV triangular 17.1±4.2 17±5.08 0.92* 0.2 -3.7–4.2 0.02
TINN [ms] 228.9±244.4 238.2±187.8 0.79* -9.2 -304.7–286.1 0.04
Frequency domain
LF (ms2) 55.3±14.9 55.7±15.3 0.86* -0.4 -16.2–15.3 0.03
HF (ms2) 44.5±14.5 43±14.2 0.82* 0.5 -16.2–17.3 0.10
LF/HF [-] 1.7±2.3 0.07±4.8 0.85* 1.8# -4.2–7.8 0.45 (small) 
Poincaré plot
SD1 [ms] 54.7±21.3 48.9± 20.05 0.93* 4.5# -10.7–19.9 0.28 (small) 
SD2 [ms] 106.2±26.9 100.8±30.9 0.92* 5.4# -18.9–29.8 0.19
SamplEn [-] 1.4±0.3 1.4±0.3 0.92* 0.03 -0.2–0.2 0.11
ApEn [-] 1.2±0.2 1.2±0.2 0.94* 0.03# -0.1–0.2 0.13
DFA_a1 [-] 1.0±0.2 1.0±0.2 0.86* 0.01 -0.2–0.2 0.06
DFA_a2 [-] 0.9±0.1 0.9±0.1 0.80* 0.0004 -0.2–0.2 0.00
Recurrence plot
Lmin [beats] 14.3±34.3 16.1±40.02 0.88* -1.8 -38.7–35.1 0.05
Lmax [beats] 279.2±201.3 297.8±205.7 0.93* -18.6 -172.7–135.5 0.09
REC [%] 34.7±9.0 34.3±9.2 0.75* 0.4 -12.3–13.1 0.05
DET [%] 97.7±0.8 97.8±0.7 0.86* -0.09 -0.9–0.7 0.12
ShanEn [-] 3.3±0.4 3.3±0.5 0.87* -0.04 -0.5–0.4 0.09
D2 [-] 2.8±1.0 2.6±1.1 0.78* 0.1 -1.2–1.6 0.14
*Significant association between ECG and Polar RS800 CX. #Significant mean differences between ECG and 
Polar RS800 CX. ‡n=32. ECG, electrocardiogram; MeanRR [ms], standard deviation of all RR intervals; STDRR 
[ms], standard deviation of normal to normal R-R intervals; MeanHR [1/min], The mean heart rate; STDHR [1/min], 
Standard deviation of instantaneous heart rate values; RMSSD [ms], root mean square of differences; pNN50, 
proportion of differences between adjacent NN intervals of more than 50ms; NN50 [beats], number of NN intervals 
that differ more than 50 ms; HRV triangular index [-], The integral of the RR interval histogram divided by the height 
of the histogram; TINN [ms], Baseline width of the RR interval histogram; LF (ms2), low frequency; HF (ms2), high 
frequency; LF/HF [-], Ratio LF [ms2]/HF [ms2]; SD1 [ms], represents the dispersion of the points along the line of 
identity and is thought to be an index of the instantaneous beat-to-beat variability of the data; SD2 [ms], represents 
the dispersion of the points along the line of identity and is thought to represent the slow variability of heart rate; 
SampIEn [-], complexity of NN series; ApEn, approximate entropy of the complexity or irregularity of the signal; 
DFA, Detrended fluctuation analysis of the correlation within the HRV signal divided into short-term and long-term 
fluctuations; Lmin (beats), mean line length; Lmax (beats), maximum line length; REC [%], recurrence rate; DET [%], 
determinism; ShanEn [-], shannon entropy consider the lengths of the diagonal lines; D2 [-], correlation dimension.
exercise period and Table 3 for the recovery period. Dataset 1 
contains all raw data obtained using both measurement 
methods26. The Bland–Altman plots for the resting, exercise 
and recovery periods, can be found in Supplementary File 1. 
Missing values were removed from the analysis and the final 
number of participants for each HRV index appears in Table 1 
for the resting period, Table 2 for the exercise period and 
Table 3 for the recovery period.
During the resting period, Polar RS800CX showed significant 
correlations (r>0.75, p<0.05) with the ECG in all studied HRV 
indices. We found one time domain (RMSSD), one frequency 
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Table 2. Heart rate variability parameters during the exercise period. Values for ECG and Polar RS 800CX 
presented as mean ± standard deviation.
Variable ECG‡ RS800CX‡ Correlation Bias LoA Effect size
Time domain
Mean RR (ms) 552.2±15.8 749.5±88.2 0.05 -197.2# -547.4–153 1.51 (large) 
STDRR(ms) 41.9±27.4, n=31 107.6±25.8 -0.42* -65.6# -153.8–22.4 2.48 (large) 
Mean HR [1/min] 117.3±14.6, n=31 92.5±10.8 0.24 24.7# -6.6–56.1 1.91 (large) 
STDHR [1/min] 11.2±2.9, n=31 12.2±2.7 0.27 -0.9 -7.7–5.7 0.34 (small) 
RMSSD (ms) 12.2±27.3, n=31 48.2±23.6 0.32 -35.9# -94.2–22.2 1.39 (large) 
NN50 [beats] 19.4±78.1, n=31 132.3±75.8 0.22 -112.9# -301.37to 75.5 1.40 (large) 
pNN50 (%) -0.08±12.2, n=31 20.6±12.7 0.24 -20.7# -50.7–9.3 1.64 (large) 
HRV triangular 7.3±3.9, n=31 14.8±3.8 0.30 -7.4# -16.5–1.5 1.92 (large) 
TINN[ms] 356.1±311.9, n=31 455.2±130.2 0.23 -99.1 -703.8–505.5 0.40 (small) 
Frequency domain
LF(ms2) 64.2±12.8, n=31 64.4±10.4 -0.07 -0.1 -33.7–33.3 0.07
HF (ms2) 35.2±13.9, n=31 34.9±10.6 0.09 0.2 -32.5–32.9 0.01
LF/HF[-] 3.2±1.7, n=31 3.7±3.5 0.24 -0.4 -7.5–6.5 0.24 (small) 
Poincaré plot
SD1[ms] 8.3±18.8, n=31 34.4±17.1 0.34 -26.06# -66.7–14.6 1.42 (large) 
SD2[ms] 57.6±36.3, n=31 149±34.2 -0.31 -91.3# -203.4–20.7 2.61 (large) 
SamplEn [-] 0.8±0.2, n=31 0.7±0.3 0.56* 0.02 -0.5–0.6 0.11
ApEn[-] 0.8±0.1, n=31 0.7±0.2 0.65* 0.09# -0.2–0.4 0.48 (small) 
DFA_a1[-] 0.9±0.2, n=31 1.1±0.1 0.08 -0.2# -0.8–0.3 1.18 (large) 
DFA_a2[-] 0.9±0.1,n=31 1.0±0.1 0.55* -0.1# -0.4–0.2 0.64 (moderate) 
Recurrence plot
Lmin [beats] 61.7±19.9, n=31 66.8±25.7 0.51* -5.02 -50.5–40.4 0.23 (small) 
Lmax [beats] 691.2±254.4, n=31 614.5±147.6 0.30 76.7 -418.3–571.8 0.35 (small) 
REC [%] 49.9±7.5, n=31 47.6±8.5 -0.12 2.2 -21.3–25.8 0.23 (small) 
DET [%] 99.6±0.8, n=31 99.1±0.9 0.47* 0.4# -1.3–2.3 0.53 (moderate) 
ShanEn[-] 4.2±0.3, n=31 4.1±0.4 0.31 0.08 -0.8–1.06 0.06
D2[-] 0.7±0.6, n=31 1.8±0.5 -0.06 -1.1# -2.9–0.7 1.73 (large) 
*Significant association between ECG and Polar RS800 CX. # Significant mean differences between ECG and Polar RS800 
CX. ‡n=32 unless indicated. ECG, electrocardiogram; MeanRR [ms], standard deviation of all RR intervals; STDRR [ms], 
standard deviation of normal to normal R-R intervals; MeanHR [1/min], The mean heart rate; STDHR [1/min], Standard deviation 
of instantaneous heart rate values; RMSSD [ms], root mean square of differences; pNN50, proportion of differences between 
adjacent NN intervals of more than 50ms; NN50 [beats], number of NN intervals that differ more than 50 ms; HRV triangular 
index [-], The integral of the RR interval histogram divided by the height of the histogram; TINN [ms], Baseline width of the RR 
interval histogram; LF (ms2), low frequency; HF (ms2), high frequency; LF/HF [-], Ratio LF [ms2]/HF [ms2]; SD1 [ms], represents 
the dispersion of the points along the line of identity and is thought to be an index of the instantaneous beat-to-beat variability 
of the data; SD2 [ms], represents the dispersion of the points along the line of identity and is thought to represent the slow 
variability of heart rate; SampIEn [-], complexity of NN series; ApEn, approximate entropy of the complexity or irregularity 
of the signal; DFA, Detrended fluctuation analysis of the correlation within the HRV signal divided into short-term and long-
term fluctuations; Lmin (beats), mean line length; Lmax (beats), maximum line length; REC [%], recurrence rate; DET [%], 
determinism; ShanEn [-], shannon entropy consider the lengths of the diagonal lines; D2 [-], correlation dimension.
domain (LF/HF) and three Poincaré plot (SD1, SD2, ApEn) 
HRV indices, to show significant mean differences (p<0.05) 
between Polar RS800CX and the ECG. Also, one time domain 
(RMSSD), one frequency domain (LF/HF) and one Poincaré 
plot (SD1) HRV indices showed small effect sizes (0.28–0.45) 
between the Polar RS800CX and the ECG (Table 1). Finally, 
during rest, the error rate of Mean RR intervals obtained from 
Polar RS800CX and the ECG, was 0.3%.
In the exercise period, one time domain (STDRR) (r=0.42, 
p<0.05), three Poincaré plot [SamplEn (r=0.56, p<0.05), ApEn 
(r=0.65, p<0.05), DFAa2 (r=0.55, p<0.05)] and two recurrence 
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Table 3. Heart rate variability indices during the recovery period. Values for ECG and Polar RS 800CX 
presented as mean ± standard deviation, n=number of cases.
Variable ECG‡ RS800CX Correlation Bias LoA Effect size
Time domain
Mean RR (ms) 807±87.08 512±112.2, n=27 0.36 294.6# 70.7–518.5 2.41 (large) 
STDRR (ms) 72.7±21.5 56.8±28.5, n=27 0.02 15.9# -53.2–85.1 0.57 (moderate) 
Mean HR [1/min] 81.5±10.4 121.8±13.9, n=27 0.29 -40.2# -69.3–-11.1 2.99 (large) 
STDHR [1/min] 6.7±3.9 11.1±4.7, n=27 -0.20 -4.4# -17.6–8.8 0.68 (moderate) 
RMSSD (ms) 53.2±30.6 2±20.1, n=27 0.39* 51.1# -6.06–108.4 1.31 (large) 
NN50 [beats] 136.6±100.4 -1.9±61.5, n=27 0.38 138.6# -48.8–326.1 1.20 (large) 
pNN50 (%) 23.4±18.3 -0.5±12.3, n=27 0.59* 23.9# -4.9–52.9 1.19 (large) 
HRV triangular 14.1±4.2 6.2±3.6, n=27 0.31 7.9# -1.1–17 1.63 (large) 
TINN [ms] 380.6±180.2 285.5±283.7, n=27 0.36 95.04 -444.4–634.5 0.44 (small) 
Frequency domain
LF (ms2) 65.7±16.2 78.9±12.9, n=27 0.20 -13.2# -49.7–23.3 0.80 (large) 
HF (ms2) 34.7±15.7 21.3±12.2, n=27 0.22 13.4# -21.1–47.9 0.87 (large) 
LF/HF [-] 2.8±2 8.3±4.4, n=27 0.13 -5.4# -14.4–3.6 1.57 (large) 
Poincaré plot
SD1 [ms] 37.6±22.8 2.4±15.4, n=28 0.17 35.1# -14.3–84.7 1.30 (large) 
SD2 [ms] 94.4±26.3 80±40.03, n=27 0.01 14.4 -78.6–107.6 0.42 (small) 
SamplEn [-] 1.2±0.3 0.6±0.3, n=27 0.21 0.6# -0.1–1.4 1.40 (large) 
ApEn [-] 1.1±0.2 0.6±0.2, n=27 0.15 0.4# -0.1–1.03 1.42 (large) 
DFA_a1 [-] 1.1±0.2 1.3±0.2, n=27 0.22 -0.1# -0.7–0.3 0.56 (moderate) 
DFA_a2 [-] 0.8±0.1 1.1±0.1, n=27 0.29 -0.2# -0.6–0.1 1.31 (large) 
Recurrence plot
Lmin [beats] 19.8±25.05 70.8±29.8, n=27 0.41* -50.9# -109.8–7.9 1.35 (large) 
Lmax [beats] 380.4±243.1 904.9±171.5, n=27 0.29 -524.5# -1019.5–-29.5 1.92 (large) 
REC [%] 38.2±9.5 53.6±8.07, n=27 0.43* -15.3# -33.9–3.1 1.34 (large) 
DET [%] 98.4±1.04 99.9±0.7, n=27 0.40* -1.4# -3.4–0.4 1.08 (large) 
ShanEn [-] 3.5±0.5 4.4±0.4, n=27 0.35 -0.9# -2.01–0.1 1.47 (large) 
D2 [-] 2.3±1.3 0.4±0.7, n=27 -0.09 1.8# -1.1–4.9 1.74 (large) 
*Significant association between ECG and Polar RS800 CX. #Significant mean differences between ECG and Polar RS800 CX. 
‡n=32. MeanRR [ms], standard deviation of all RR intervals; STDRR [ms], standard deviation of normal to normal R-R intervals; 
MeanHR [1/min], The mean heart rate; STDHR [1/min], Standard deviation of instantaneous heart rate values; RMSSD [ms], root 
mean square of differences; pNN50, proportion of differences between adjacent NN intervals of more than 50ms; NN50 [beats], 
number of NN intervals that differ more than 50 ms; HRV triangular index [-], The integral of the RR interval histogram divided 
by the height of the histogram; TINN [ms], Baseline width of the RR interval histogram; LF (ms2), low frequency; HF (ms2), high 
frequency; LF/HF [-], Ratio LF [ms2]/HF [ms2]; SD1 [ms], represents the dispersion of the points along the line of identity and is 
thought to be an index of the instantaneous beat-to-beat variability of the data; SD2 [ms], represents the dispersion of the points 
along the line of identity and is thought to represent the slow variability of heart rate; SampIEn [-], complexity of NN series; 
ApEn, approximate entropy of the complexity or irregularity of the signal; DFA, Detrended fluctuation analysis of the correlation 
within the HRV signal divided into short-term and long-term fluctuations; Lmin (beats), mean line length; Lmax (beats), maximum 
line length; REC [%], recurrence rate; DET [%], determinism; ShanEn [-], shannon entropy consider the lengths of the diagonal 
lines; D2 [-], correlation dimension.
plot [Lmin (r=0.51, p<0.05), DET (r=0.47, p<0.05)] HRV 
indices showed significant correlations between Polar RS800CX 
and the ECG. However, we detected seven out of nine time 
domain, five out of six Poincaré plot and two out of six 
recurrence plot HRV indices to display significant mean 
differences (p<0.05) between Polar RS800CX and the ECG. 
Small to large effect sizes (0.23–2.61) found in 20 out of the 
24 examined HRV indices between Polar RS800CX and the 
ECG (Table 2). Finally, during exercise, the error rate of 
Mean RR intervals obtained from the Polar RS800CX and the 
ECG, was 28.1%.
During the recovery period, two time domain (RMSSD, 
pNN50) and three recurrence plot (Lmin, REC, DET) HRV 
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indices showed significant correlations (r=0.39–0.59, p<0.05) 
between Polar RS800CX and the ECG. In total, eight out of nine 
time domain, all the frequency domain, five out of six Poincaré 
plot and all the recurrence plot HRV indices showed signifi-
cant mean differences (p<0.05) between Polar RS800CX and the 
ECG. All the HRV indices showed small to large effect sizes 
(0.42–2.99) between Polar RS800CX and the ECG (Table 3). 
Finally, during recovery, the error rate of Mean RR 
intervals obtained from Polar RS800CX and the ECG, was 68.3%.




The aim of the current study was to assess the validity of Polar 
RS800CX in a large spectrum of HRV parameters by com-
paring it with a 12-lead ECG monitor during rest, moderate 
cycling and recovery. We found that all the HRV indices (n=24) 
based on Polar RS800CX are correlated, while only five HRV 
indices displayed mean differences with the ECG HRV indices 
during the resting period. This confirms recent data showing that 
Polar RS800CX is valid for resting HRV measurements19–21,27,28. 
However, we confirmed for the first time that this is the case 
for the wide spectrum of HRV indices. Also, the majority of the 
previous studies showed that other Polar HR monitors (i.e. 
S810, 810s, S810i, V800) showed good agreement with ECG in 
detecting RR intervals in supine and standing positions of 
adult individuals5,18,23, and children24,29. One previous study 
nevertheless, showed a bias of the Polar S810 in detecting 
HRV indices in supine and standing positions during rest30. 
During the exercise period, Polar RS800CX displayed a 
disagreement with the ECG in HRV indices. The error rate of 
Mean RR intervals obtained from Polar RS800CX and the ECG 
in our study was 28.1%. This is significantly higher than the error 
rate (0.71%) of RR intervals in a previous similar study exam-
ined the validity of Polar V800 during exercise31. Also, a previous 
study showed similar bias of Polar S810 HR monitor during 
exercise in high frequency (HF) HRV index at intensities >60% 
of VO
2
 max and low frequency (LF) HRV index at intensi-
ties 80–100% of VO
2
 max, even though the HR monitor found 
relatively valid in exercise intensities <60% of VO
2
 max29. 
Subsequent studies showed the Polar S810 had no bias dur-
ing exercise18 and Polar V800 during high endurance running31. 
Reasons that Polar HR monitors may display bias in meas-
uring HRV indices during exercise include: a) the insecure 
placement of the elastic band on the thorax; b) the movement of 
the ECG electrodes during exercise, given that our participants 
were healthy and they showed no arrhythmia; c) the 
corresponding transmission of the data from the HR moni-
tors; and d) changes of R-wave detection and the peak detection 
algorithms used29,32–35. 
Regarding the recovery period, the existing evidence is 
rather scarce. In our study, we found that the Polar RS800CX 
displayed bias in the recovery period. For instance, the error 
rate of mean RR intervals obtained from the Polar RS800CX 
and the ECG, was 68.3%. Perhaps some of the reasons 
reported above for the displayed bias during stress/exercise 
conditions may also apply to the recovery stage. 
A limitation of the current study might be the small sample 
size of participants. However, a post-measurement online 
power calculation (DSS Research), using as an index the resting 
RS800CX Mean RR HRV index of the current study and the 
resting RS800CX Mean RR HRV index from a previous similar 
study19, showed 100% of statistical power (n=32) in our study. 
Another limitation might be that only males participated in 
this study and, therefore, our outcomes should be treated with 
caution when apply to females. However, we used a well- 
established statistical approach, as previously described19,21,23,31. 
Finally, even though an investigator continuously checked the 
displacement of the chest belt and the electrodes of the Polar 
RS800CX and the ECG respectively, there is a possibility of 
a displacement due to sweating during the exercise and 
recovery periods, as previously suggested36. 
We conclude that Polar RS800CX found to be a valid tool 
for monitoring HRV during resting periods, but not for assess-
ments during exercise at intensity of 60% VO
2
 max and recovery 
periods. Testing the validity of devices such as Polar monitors 
in stressful (hot/cold or extreme) conditions such as exercise, 
requires further scientific attention, given that these instruments 
could provide a cost-effective method for monitoring HRV.
Data availability




The author(s) declared that no grants were involved in supporting 
this work.
Supplementary material
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